The investigation prospect application of alcohol-water extract of lingonberry as antimicrobial, anti-fungi and antioxidant pharmaceutical
Abstract
Infection diseases is a worldwide important problem for medicine and pharmacy. Every year 13.7 million people die from bacterial infections in the world. Thus, the search of new compounds with antimicrobial and anti-fungi activity is topical for today. The object of the study was lingonberry leaf 60% extract. The content of phenylpropanoids derivatives was evaluated by spectrophotometric method of analysis, whereas organic acids by alkalimetric method; antioxidant power was found by potentiometric method; antibacterial and antifungal activity was assessed by the method of “wells”.
According to the results of the study, it was shown that the lingonberry leaf extract is inferior to the green tea leaf extract in terms of the content of phenolic compounds, catechins, hydroxycinnamic and organic acids, but flavonoids dominate in the lingonberry extract. The study found that lingonberry leaf extract has a high level of antioxidant activity. When comparing the levels of antioxidant action of lingonberry extract with green tea extract and the «gold standard» – аepigallocatechin-3-O-gallate in one concentration of 0.03 mol/L, it was found that lingonberry extract had the best result. Escherichia coli bacteria was the most sensitive to the extract whereas Pseudomonas aeruginosa was the most resistant.
This work shows that 60% ethanolic lingonberry leaf extract has potent antioxidant, antimicrobial and antifungal effects. According to the obtained results, it can be concluded that 60% V. vitis-idaea leaf extract is promising for the development of new antimicrobial, antifungal and antioxidant pharmaceutical.
References
2 Gomes FMS, da Cunha Xavier J, dos Santos JFS, de Matos YML S, Tintino SR, et al (2018) Microb Pathogenesis 115:175–178. Crossref
3 Nisar B, Sultan A, Rubab SL (2018) Natural Products Chemistry & Research 06(02):175-178. Crossref
4 Xu J, Yang H, Nie C, Wang T, Qin X, et al (2023) RSC Adv 13(42):29438-49. Crossref
5 Komisarenko МА, Heiderykh АS, Kovalyova АМ, Koshovyi ОМ (2012) Ukrainian Journal of Clinical and Laboratory Medicine [Ukrainskyi zhurnal klinichnoi ta laboratornoi medytsyny] 7(2):24–26. (In Ukrainian)
6 Komisarenko МА, Koshovyi ОМ, Kovalyova АМ, Sydora NV (2014) Collection of scientific works of employees of NMAPO named after PL [Shupyk Zbirnyk naukovykh prats spivrobitnykiv NMAPO imeni P.L. Shupyka] 23(4):291–295. (In Ukrainian)
7 Röhrl C, Steinbauer S, Bauer R, Roitinger E, Otteneder K, et al (2021) Food Amp Funct 12(21):10432-10442. Crossref
8 Tian Y, Puganen A, Alakomi H-L, Uusitupa A, Saarela M, Yang B (2018) Food Res Int 106:291–303. Crossref
9 Kowalska K (2021) Lingonberry (Vaccinium vitis-idaea L.) International Journal of Molecular Sciences 22(10):5126. Crossref
10 Vyas P, Kalidindi S, Chibrikova L, Igamberdiev AU, Weber JT (2013) J Agr Food Chem 61(32):7769–7776. Crossref
11 Ferlemi A-V, Lamari F (2016) Antioxidants 5(2):17. Crossref
12 Raudone L, Vilkickyte G, Pitkauskaite L, Raudonis R, Vainoriene R, Motiekaityte V (2019) Molecules 24(5):844. Crossref
13 Bujor O-C, Ginies C, Popa VI, Dufour C (2018) Food Chem 252:356–365. Crossref
14 Ștefănescu B-E, Călinoiu LF, Ranga F, Fetea F, Mocan A, et al (2020) Antioxidants 9(6):495. Crossref
15 Maslov OY, Kolisnyk SV, Komisarenko MA, Kolisnyk OV, Ponomarenko SV (2021) Pharmacologyonline (3):291-8. Crossref
16 Maslov O, Kolisnyk S, Komisarenko M, Golik M (2022) Herba Polonica 68(1):1-9. Crossref
17 Maslov OY, Komisarenko MA, Golik MY, Kolisnyk SV, Altukhov AA, et al (2023) Vitae 30(1):1-8. Crossref
18 Maslov O, Komisarenko M, Kolisnyk S, Kostina T, Golik M, et al (2023) Current Issues in Pharmacy and Medical Sciences 36(4):194-198. Crossref
19 Maslov O, Kolesnik S, Komisarenko M, Altukhov A, Dynnyk K, Kostina T (2021) Pharmakeftiki 33(4):304–311. Crossref
20 Maslov OY, Kolisnyk SV, Komissarenko NA, Kostina TA (2021) Pharmacologyonline 2:35-42. Crossref
21 Maslov OY, Komisarenko MA, Horopashna DO, Tkachenko OV, Derymedvid LV, et al (2023) Herba Polonica 69(4):45–53. Crossref
22 Volyanskiy Y, Gritsenko I, Shyrokobokov V (2004) The study of the specific activity of antimicrobial drugs: a method recommendation [Vyvchennya spetsyfichnoyi aktyvnosti antymikrobnykh preparativ: metod.rekomend]. StEntScPhC Ministry of Helthcare of Ukraine, Ukraine. [StEntScPhC MOZ Ukrayiny, Ukrayina.] (In Ukrainian)
23 Volyanskiy YL, Mironenko LG, Kalinichenko SV (2006) Standardization of the preparation of microbial suspensions. Newsletter of innovations in health care No.163-2006 [Standartyzatsiya pryhotuvannya mikrobnykh suspenziy. Byuletenʹ innovatsiy v okhoroni zdorov’ya №163-2006]. Ministry of Health Care of Ukraine [MOZ Ukrayiny] (In Ukrainian)
24 Bujor OC, Ginies C, Popa VI, Dufour C (2018) Food Chem 252:356-365. Crossref
25 Maslov OY, Kolisnyk SV, Komisarenko MA, Altukhov AA, Dynnyk KV, Stepanenko VI (2021) Current Issues in Pharmacy and Medicine: Science and Practice 14(2):215–219. Crossref
26 Kryvtsova MV, Salamon I, Koscova J, Spivak MY (2020) Biosyst Divers 28(3):238-242. Crossref
27 Ștefănescu BE, Călinoiu LF, Ranga F, Fetea F, Mocan A, Vodnar DC, Crișan G (2020) Antioxidants 9(6):495. Crossref
28 Mirazi N, Baharvand F, Moghadasali R, Nourian A, Hosseini A (2020) Basic Clin Pharmacol 128(2):268–274. Crossref
29 Hamilton KS, Gopal KV, Moore EJ, Gross GW (2017) Eur J Pharmacol 794:92-99. Crossref
30 Petejova N, Martinek A, Zadrazil J, Kanova M, Klementa V, et al (2020) Int J Mol Sci 21(19):7115. Crossref
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.